Abnormal thyroxine metabolism in hyposomatotrophic dwarfism and inhibition of responsiveness to TRH during GH therapy.
D000293:Adolescent; D002648:Child; D004393:Dwarfism, Pituitary / Q000188:drug therapy / Q000378:metabolism*; D005260:Female; D013006:Growth Hormone / Q000008:administration & dosage / Q000009:adverse effects* / Q000037:antagonists & inhibitors / Q000378:metabolism / Q000627:therapeutic use*; D006801:Humans; D007037:Hypothyroidism / Q000188:drug therapy / Q000378:metabolism; D008297:Male; D013972:Thyrotropin / Q000037:antagonists & inhibitors / Q000378:metabolism*; D013973:Thyrotropin-Releasing Hormone / Q000037:antagonists & inhibitors / Q000378:metabolism; D013974:Thyroxine / Q000378:metabolism
D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin; D013006:Growth Hormone; D013974:Thyroxine